Lume 5.8
metadata only
Efficacy of milnacipran in treating anxiety symptoms in schizophrenic patients receiving clozapine : a case series study
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- An Adaptive Phase II/III, Two-Part, Double-Blind, Randomized, Placebo-controlled, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen®, as an Add-on Therapy With Clozapine, for Residual Symptoms of Refractory Schizophrenia in Adults#1059431
- Biomarker and Safety Study of Clozapine in Patients With Benign Ethnic Neutropenia (BEN)#1007975
- fMRI Study Examining Effects of D-cycloserine in Specific Phobia#883418
- Seizures associated with clozapine augmentation by other antipsychotics: a pharmacovigilance–pharmacodynamic analysis using VigiBase#1054556
- Identifying people with psychotic illnesses who could reduce or discontinue antipsychotic medications with a lower risk of relapse: a scoping review#1108208
Record · ID 468571
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive